(2S)-2-[4-[(1S)-5-(4-butoxyphenyl)-1-carboxypentyl]-7,10-bis[(1S)-1-carboxylato-2-hydroxyethyl]-1,4,7,10-tetrazacyclododec-1-yl]-3-hydroxypropanoate;gadolinium(3+)

C33H51GdN4O12 — CID 175792896

IUPAC(2S)-2-[4-[(1S)-5-(4-butoxyphenyl)-1-carboxypentyl]-7,10-bis[(1S)-1-carboxylato-2-hydroxyethyl]-1,4,7,10-tetrazacyclododec-1-yl]-3-hydroxypropanoate;gadolinium(3+)
SMILESCCCCOc1ccc(CCCC[C@@H](C(=O)O)N2CCN([C@@H](CO)C(=O)[O-])CCN([C@@H](CO)C(=O)[O-])CCN([C@@H](CO)C(=O)[O-])CC2)cc1.[Gd+3]
InChIInChI=1S/C33H54N4O12.Gd/c1-2-3-20-49-25-10-8-24(9-11-25)6-4-5-7-26(30(41)42)34-12-14-35(27(21-38)31(43)44)16-18-37(29(23-40)33(47)48)19-17-36(15-13-34)28(22-39)32(45)46;/h8-11,26-29,38-40H,2-7,12-23H2,1H3,(H,41,42)(H,43,44)(H,45,46)(H,47,48);/q;+3/p-3/t26-,27-,28-,29-;/m0./s1
InChIKeyIFAYQIOZQYAGBL-MROKUPSKSA-K
MW853.04 g/mol
LogP-4.41
Rot. Bonds20

About (2S)-2-[4-[(1S)-5-(4-butoxyphenyl)-1-carboxypentyl]-7,10-bis[(1S)-1-carboxylato-2-hydroxyethyl]-1,4,7,10-tetrazacyclododec-1-yl]-3-hydroxypropanoate;gadolinium(3+)

(2S)-2-[4-[(1S)-5-(4-butoxyphenyl)-1-carboxypentyl]-7,10-bis[(1S)-1-carboxylato-2-hydroxyethyl]-1,4,7,10-tetrazacyclododec-1-yl]-3-hydroxypropanoate;gadolinium(3+) (PubChem CID 175792896) has the molecular formula C33H51GdN4O12 and a molecular weight of 853.04 g/mol. Its IUPAC name is (2S)-2-[4-[(1S)-5-(4-butoxyphenyl)-1-carboxypentyl]-7,10-bis[(1S)-1-carboxylato-2-hydroxyethyl]-1,4,7,10-tetrazacyclododec-1-yl]-3-hydroxypropanoate;gadolinium(3+).

Molecular Properties

Compound Name(2S)-2-[4-[(1S)-5-(4-butoxyphenyl)-1-carboxypentyl]-7,10-bis[(1S)-1-carboxylato-2-hydroxyethyl]-1,4,7,10-tetrazacyclododec-1-yl]-3-hydroxypropanoate;gadolinium(3+)
PubChem CID175792896
Molecular FormulaC33H51GdN4O12
Molecular Weight853.04 g/mol
Exact Mass853.27
IUPAC Name(2S)-2-[4-[(1S)-5-(4-butoxyphenyl)-1-carboxypentyl]-7,10-bis[(1S)-1-carboxylato-2-hydroxyethyl]-1,4,7,10-tetrazacyclododec-1-yl]-3-hydroxypropanoate;gadolinium(3+)
SMILESCCCCOc1ccc(CCCC[C@@H](C(=O)O)N2CCN([C@@H](CO)C(=O)[O-])CCN([C@@H](CO)C(=O)[O-])CCN([C@@H](CO)C(=O)[O-])CC2)cc1.[Gd+3]
InChIInChI=1S/C33H54N4O12.Gd/c1-2-3-20-49-25-10-8-24(9-11-25)6-4-5-7-26(30(41)42)34-12-14-35(27(21-38)31(43)44)16-18-37(29(23-40)33(47)48)19-17-36(15-13-34)28(22-39)32(45)46;/h8-11,26-29,38-40H,2-7,12-23H2,1H3,(H,41,42)(H,43,44)(H,45,46)(H,47,48);/q;+3/p-3/t26-,27-,28-,29-;/m0./s1
InChIKeyIFAYQIOZQYAGBL-MROKUPSKSA-K
XLogP-4.41
TPSA240.57 Ų
H-Bond Donors4
H-Bond Acceptors15
Rotatable Bonds20
Heavy Atoms50
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500853.04
LogP ≤ 5-4.41
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1015

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze (2S)-2-[4-[(1S)-5-(4-butoxyphenyl)-1-carboxypentyl]-7,10-bis[(1S)-1-carboxylato-2-hydroxyethyl]-1,4,7,10-tetrazacyclododec-1-yl]-3-hydroxypropanoate;gadolinium(3+) with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (2S)-2-[4-[(1S)-5-(4-butoxyphenyl)-1-carboxypentyl]-7,10-bis[(1S)-1-carboxylato-2-hydroxyethyl]-1,4,7,10-tetrazacyclododec-1-yl]-3-hydroxypropanoate;gadolinium(3+)?
The IUPAC name of (2S)-2-[4-[(1S)-5-(4-butoxyphenyl)-1-carboxypentyl]-7,10-bis[(1S)-1-carboxylato-2-hydroxyethyl]-1,4,7,10-tetrazacyclododec-1-yl]-3-hydroxypropanoate;gadolinium(3+) (CID 175792896) is (2S)-2-[4-[(1S)-5-(4-butoxyphenyl)-1-carboxypentyl]-7,10-bis[(1S)-1-carboxylato-2-hydroxyethyl]-1,4,7,10-tetrazacyclododec-1-yl]-3-hydroxypropanoate;gadolinium(3+).
What is the SMILES notation for (2S)-2-[4-[(1S)-5-(4-butoxyphenyl)-1-carboxypentyl]-7,10-bis[(1S)-1-carboxylato-2-hydroxyethyl]-1,4,7,10-tetrazacyclododec-1-yl]-3-hydroxypropanoate;gadolinium(3+)?
The canonical SMILES for (2S)-2-[4-[(1S)-5-(4-butoxyphenyl)-1-carboxypentyl]-7,10-bis[(1S)-1-carboxylato-2-hydroxyethyl]-1,4,7,10-tetrazacyclododec-1-yl]-3-hydroxypropanoate;gadolinium(3+) is CCCCOc1ccc(CCCC[C@@H](C(=O)O)N2CCN([C@@H](CO)C(=O)[O-])CCN([C@@H](CO)C(=O)[O-])CCN([C@@H](CO)C(=O)[O-])CC2)cc1.[Gd+3].
What is the InChIKey of (2S)-2-[4-[(1S)-5-(4-butoxyphenyl)-1-carboxypentyl]-7,10-bis[(1S)-1-carboxylato-2-hydroxyethyl]-1,4,7,10-tetrazacyclododec-1-yl]-3-hydroxypropanoate;gadolinium(3+)?
The InChIKey is IFAYQIOZQYAGBL-MROKUPSKSA-K. The full InChI is InChI=1S/C33H54N4O12.Gd/c1-2-3-20-49-25-10-8-24(9-11-25)6-4-5-7-26(30(41)42)34-12-14-35(27(21-38)31(43)44)16-18-37(29(23-40)33(47)48)19-17-36(15-13-34)28(22-39)32(45)46;/h8-11,26-29,38-40H,2-7,12-23H2,1H3,(H,41,42)(H,43,44)(H,45,46)(H,47,48);/q;+3/p-3/t26-,27-,28-,29-;/m0./s1.
What are the key properties of (2S)-2-[4-[(1S)-5-(4-butoxyphenyl)-1-carboxypentyl]-7,10-bis[(1S)-1-carboxylato-2-hydroxyethyl]-1,4,7,10-tetrazacyclododec-1-yl]-3-hydroxypropanoate;gadolinium(3+)?
(2S)-2-[4-[(1S)-5-(4-butoxyphenyl)-1-carboxypentyl]-7,10-bis[(1S)-1-carboxylato-2-hydroxyethyl]-1,4,7,10-tetrazacyclododec-1-yl]-3-hydroxypropanoate;gadolinium(3+) has a molecular weight of 853.04 g/mol, XLogP of -4.41, 20 rotatable bonds, 4 hydrogen bond donors, and 15 hydrogen bond acceptors.
Where does this data come from?
All data for (2S)-2-[4-[(1S)-5-(4-butoxyphenyl)-1-carboxypentyl]-7,10-bis[(1S)-1-carboxylato-2-hydroxyethyl]-1,4,7,10-tetrazacyclododec-1-yl]-3-hydroxypropanoate;gadolinium(3+) is sourced from PubChem (CID 175792896), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).